Table 7 Medication intake across cohorts

From: Explainable AI associates ECG aging effects with increased cardiovascular risk in a longitudinal population study

Cohort

Metformin (%)

Insulin (%)

Hypertensives (%)

Beta blocker (%)

Calcium channel blocker (%)

Antiarrhythmic (%)

START-0

4.60

2.30

27.77

1.53

1.72

3.85

START-1

1.53

2.12

26.47

0.29

2.91

1.26

START-2

1.63

2.05

29.95

0.12

3.07

0.55

START-3

1.55

1.80

28.59

0.13

2.89

0.33

TREND-0

1.77

1.80

31.12

0.19

2.82

0.61

TREND-1

1.59

1.38

27.02

0.09

2.67

0.35

  1. The table provides insights into medication usage patterns within the study population.